| scholarly article | Q13442814 |
| P2093 | author name string | Sanjiv J Shah | |
| John Varga | |||
| Monique Hinchcliff | |||
| Chintan S Desai | |||
| P2860 | cites work | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
| Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve | Q33579068 | ||
| Polymyositis and dermatomyositis (second of two parts) | Q33909233 | ||
| Polymyositis and dermatomyositis (first of two parts) | Q33911013 | ||
| ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American Co | Q34971421 | ||
| Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In | Q34999923 | ||
| The heart in systemic sclerosis | Q35689002 | ||
| Heart involvement and systemic sclerosis. | Q36283456 | ||
| Detecting subclinical biventricular impairment in scleroderma patients by use of pulsed-wave tissue Doppler imaging. | Q37177833 | ||
| Systemic sclerosis and cardiac dysfunction: evolving concepts and diagnostic methodologies | Q37306418 | ||
| Recommendations for the evaluation of left ventricular diastolic function by echocardiography | Q37383745 | ||
| Cardiac complications of systemic sclerosis | Q37504315 | ||
| Assessment of the right ventricle by echocardiography: a primer for cardiac sonographers | Q37533533 | ||
| Heart involvement in systemic sclerosis: evolving concept and diagnostic methodologies | Q37689351 | ||
| Evolving focus on diastolic dysfunction in patients with coronary artery disease | Q37786495 | ||
| Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee | Q39513167 | ||
| Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis | Q39877290 | ||
| Cardiac involvement in scleroderma | Q41220227 | ||
| Survival with scleroderma—II: A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients | Q45337964 | ||
| Myocardial contractility is early affected in systemic sclerosis: a tissue Doppler echocardiography study. | Q52991983 | ||
| Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio | Q57217547 | ||
| Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis | Q61895150 | ||
| Scleroderma (systemic sclerosis): classification, subsets and pathogenesis | Q68330753 | ||
| Left ventricular function in scleroderma | Q71710138 | ||
| Heart structure and function in systemic sclerosis | Q78014518 | ||
| Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial | Q80515232 | ||
| Detection of subclinical cardiac involvement in systemic sclerosis by echocardiographic strain imaging | Q80685970 | ||
| The heart in scleroderma | Q80842711 | ||
| Tissue Doppler echocardiography and myocardial performance index in patients with scleroderma | Q81070627 | ||
| Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients | Q81361071 | ||
| Regional diastolic function by tissue Doppler echocardiography in systemic sclerosis: correlation with clinical variables | Q83106907 | ||
| Angiographically proven coronary artery disease in scleroderma | Q83136221 | ||
| P433 | issue | 2 Suppl 71 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diastole | Q492905 |
| Diastolic function | Q30314111 | ||
| P304 | page(s) | S30-7 | |
| P577 | publication date | 2012-03-01 | |
| P1433 | published in | Clinical and Experimental Rheumatology | Q15759225 |
| P1476 | title | Prevalence, prognosis, and factors associated with left ventricular diastolic dysfunction in systemic sclerosis | |
| P478 | volume | 30 |
| Q36777766 | 2014 Guidelines of Taiwan Society of Cardiology (TSOC) for the Management of Pulmonary Arterial Hypertension |
| Q41169103 | Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis. |
| Q42341882 | Autoimmune myocarditis in systemic sclerosis: an unusual form of scleroderma heart disease presentation. |
| Q48148896 | Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort |
| Q41641441 | Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance |
| Q47633128 | Determinants of mortality in systemic sclerosis: a focused review |
| Q61913936 | Diffuse cardiac fibrosis quantification in early systemic sclerosis by magnetic resonance imaging and correlation with skin fibrosis |
| Q38866037 | Echocardiography in the Assessment of Patients with Rheumatologic Diseases |
| Q47164098 | Evaluation of Left Ventricular Diastolic Function by Echocardiography with Tissue Doppler in Systemic Sclerosis |
| Q33935334 | Heart diastolic dysfunction in patients with systemic sclerosis |
| Q92060984 | Left atrial stiffness is superior to volume and strain parameters in predicting elevated NT-proBNP levels in systemic sclerosis patients |
| Q36416955 | Left ventricular diastolic dysfunction in pulmonary hypertension predicts functional capacity and clinical worsening: a tissue phase mapping study |
| Q38163917 | Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries |
| Q30458135 | Role of 2D strain in the early identification of left ventricular dysfunction and in the risk stratification of systemic sclerosis patients |
| Q36150934 | Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans |
| Q64078682 | Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature |
| Q30564455 | Text data extraction for a prospective, research-focused data mart: implementation and validation |
Search more.